78 /100
CRITICAL RISK
Score updated May 29, 2026

ONCO — Onconetix, Inc. Dilution Risk Tracker

Track ONCO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ONCO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
65
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
43%
🔁 Convertible Conversion 60%
• Major convertible overhang: 3383% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 35%
• Under 12 months cash (7mo)
• Active shelf registration ($25M, 1864% of market cap)
📉 Score Deterioration 15%
• Score already CRITICAL (78/100) — events likely imminent
🔔 Track ONCO — Get forecast alerts →

💹 Market Data

Market Cap$1.34M
Shares Outstanding1.15M
FloatN/A
Cash$3.72M
Debt$289.9K
Short InterestN/A

🏛 Institutional Holdings

6 institutional holders · 12.2K shares
#1 DRW Securities, LLC 7.8K shares
#2 Xtx Topco Ltd 2.2K shares
#3 UBS Group AG 1.8K shares
+ 3 more holders Sign up free to view →

📉 Short Interest

Short Interest522.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 23, 2025
S-1 SHELF Apr 28, 2026
4 INSIDER TRANSACTION Apr 22, 2026
4 INSIDER TRANSACTION Apr 21, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ONCO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ONCO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ONCO
📊 ONCO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ONCO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.